Evidence map›Paper›PMID 32029819›Full record

ArticleScientific reports2020

A pilot study of alterations in oxidized angiotensinogen and antioxidants in pre-eclamptic pregnancy.

Lina A Dahabiyeh, David Tooth, Lesia O Kurlak, Hiten D Mistry, Fiona Broughton Pipkin, David A Barrett

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. The Molecular Pathology of Pre-Eclamptic Hypertension.Current issues in molecular biology · 2025
    Article
  4. Review
  5. Genetic Variations inJournal of clinical medicine · 2023
    Article
  6. Article
  7. Angiotensinogen and the Modulation of Blood Pressure.Frontiers in cardiovascular medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Lina A DahabiyehDepartment of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman, Jordan.
David ToothBBSRC/EPSRC Synthetic Biology Research Centre, School of Life Sciences, University of Nottingham, Nottingham, UK.
Lesia O KurlakDivision of Child Health, Obstetrics and Gynaecology, School of Medicine; University of Nottingham, Nottingham, UK.
Hiten D MistryDivision of Child Health, Obstetrics and Gynaecology, School of Medicine; University of Nottingham, Nottingham, UK. hiten.mistry@nottingham.ac.uk.
Fiona Broughton PipkinDivision of Child Health, Obstetrics and Gynaecology, School of Medicine; University of Nottingham, Nottingham, UK.
David A BarrettCentre for Analytical Bioscience, Division of Advanced Materials and Healthcare Technologies, School of Pharmacy, University of Nottingham, Nottingham, UK.
University of Nottingham · GBBiotechnology and Biological Sciences Research Council · GBUniversity of Jordan · JO

Funding

British Heart Foundation FS/15/32/31604
6 · The paper itself

Abstract

The oxidation status of angiotensinogen (AGT) may have a critical role in pre-eclampsia. We used a validated, quantitative, mass spectrometry-based method to measure the oxidized and total AGT levels in plasma of pre-eclamptic women (n = 17), normotensive-matched controls (n = 17), and healthy non-pregnant women (n = 10). Measurements of plasma glutathione peroxidase (GPx) activity and serum selenium concentrations were performed as markers of circulating antioxidant capacity. Higher proportions of oxidized AGT in plasma from pre-eclamptic women compared to matched normotensive pregnant controls (P = 0.006), whilst maintaining a similar total plasma AGT concentration were found. In the pre-eclamptic group, blood pressure were correlated with the proportion of oxidized AGT; no such correlation was seen in the normotensive pregnant women. Plasma GPx was inversely correlated with oxidized AGT, and there was an inverse association between serum selenium concentration and the proportion of oxidized AGT. This is the first time that oxidized AGT in human plasma has been linked directly to antioxidant status, providing a mechanism for the enhanced oxidative stress in pre-eclampsia. We now provide pathophysiological evidence that the conversion of the reduced form of AGT to its more active oxidized form is associated with inadequate antioxidant status and could indeed contribute to the hypertension of pre-eclampsia.

Indexed as

AdultAngiotensinogenAntioxidantsBiomarkersBlood PressureFemaleGlutathione PeroxidaseHumansOxidation-ReductionOxidative StressPilot ProjectsPlacentaPre-EclampsiaPregnancySeleniumAngiotensinogenAntioxidantsBiomarkersGlutathione PeroxidaseSelenium

Identifiers

PMID32029819
PMCPMC7004983
OpenAlexW3005094052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.